Cat. No.: X23-10-ZQ374
JAK inhibitor Delgocitinib, Purity ≥98%
Synonym: Delgocitinib; 1263774-59-9; JTE-052; JTE-052A; Corectim; LEO 124249A; LEO 124249; JAK inhibitor
- CAS Number: 1263774-59-9
- Compound CID: 50914062
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Properties
Description
Delgocitinib is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, JAK3, and TYK2.
Molecular Formula
C16H18N6O
Targets
JAK1: 2.8 nM; JAK2: 2.6 nM; JAK3: 13 nM; TYK2: 58 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
Delgocitinib can be employed to study JAK inhibition and its effects in dermatological and inflammatory conditions.
Related Products
-
JAK inhibitor JAK/HDAC-IN-1, Purity ≥98%
-
JAK inhibitor 1,2,3,4,5,6-Hexabromocyclohexane, Purity ≥98%
-
JAK inhibitor Abrocitinib, Purity ≥98%
-
JAK inhibitor AZ-3, Purity ≥98%
-
JAK inhibitor AZ-960, Purity ≥98%
-
JAK inhibitor AZD1480, Purity ≥98%
Quick Links